Combination of fractional carbon dioxide laser and topical triamcinolone vs intralesional triamcinolone for keloid treatment: A randomised clinical trial. Issue 7 (14th February 2022)

• Record Type: Journal Article
• Authors: Tawaranurak, Niti; Pliensiri, Pitchaya; Tawaranurak, Krongthong
• Is Part Of: International wound journal. Volume 19:Issue 7(2022)
• Page Start: 1729
• Page End: 1735
• Publication Date: 2022-02-14
• Subjects: fractional carbon dioxide laser -- intralesional triamcinolone -- keloid treatment -- topical triamcinolone; Wounds and injuries -- Treatment -- Periodicals; Wounds and injuries -- Periodicals; Wound healing -- Periodicals; 617.1005
• DOI: 10.1111/iwj.13775
• Languages: English
• ISSNs: 1742-4801

Abstract

Abstract: To compare the therapeutic effect of fractional carbon dioxide (CO2 ) laser + topical triamcinolone (TA) with intralesional TA on keloids. Twenty‐two participants were randomised into two groups: group A, treated with fractional CO2 laser + topical TA, and group B, treated with intralesional TA. The interventions were performed at every 4‐week interval until the keloids were resolved or at the completion of 1 year. At each session, the scar volume, Vancouver Scar Scale (VSS) were assessed. Recurrence was observed for 1 year. The mean scar volumes and VSS scores were not significantly different between the two groups. After 1 year, the scar volume change in group B was greater than group A (86.5% vs 59.1%, P ‐value = .016). The mean VSS scores were significantly decreased in group A (8.0 ± 1.5 to 4.8 ± 1.6, P ‐value <.001) and group B (8.4 ± 0.8 to 4.8 ± 1.6, P ‐value <.001). The keloids were completely resolved in 63.6% and 72.7% of the patients, and recurrence was observed in 9.1% and 18.2% of the patients in groups A and B, respectively. The combination of fractional CO2 laser with topical TA was an alternative option for the treatment of keloids.